VIPDOMET

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug VIPDOMET contains a combination of these active pharmaceutical ingredients (APIs):

1 Alogliptin UNII JHC049LO86 - ALOGLIPTIN

Alogliptin is a potent and highly selective inhibitor of DPP-4, >10,000-fold more selective for DPP-4 than other related enzymes including DPP-8 and DPP-9. Alogliptin improves glycaemic control via a glucose-dependent mechanism, whereby insulin release is enhanced and glucagon levels are suppressed when glucose levels are high. Read about Alogliptin

2 Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. Read about Metformin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIPDOMET Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BD13	Metformin and alogliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1627028, 1627039, 1627040, 1627051, 1627062, 1627073, 1627084, 1627095, 1627107, 1627118, 1627129, 1627130, 1627141, 1627152, 1627163, 1627174, 1627185, 1627196, 1627208, 1627219, 1627220, 1627231, 1627242, 1627253, 1836749, 1836750
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 113843005, 113843008, 113843017, 113843020
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 470763
Country: FR	Base de données publique des médicaments	Identifier(s): 66037572, 66741854
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 236328, 381747, 392398
Country: IT	Agenzia del Farmaco	Identifier(s): 043045018, 043045020, 043045032, 043045044, 043045057, 043045069, 043045071, 043045083, 043045095, 043045107, 043045119, 043045121, 043045133, 043045145, 043045158, 043045160, 043045172, 043045184, 043045196, 043045208, 043045210, 043045222, 043045234, 043045246, 043045259, 043045261
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1071444, 1071445, 1071446, 1071447, 1071448, 1071449, 1071450, 1071451, 1071452, 1071453, 1071454, 1071455, 1071456, 1071457, 1071458, 1071459, 1071460, 1071461, 1071462, 1071463, 1071464, 1071465, 1071466, 1071467, 1075882, 1075883
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100313894, 100313902